DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,240,238 | -64.3% | 175,148 | -74.7% | 0.03% | -64.0% |
Q2 2022 | $9,086,650 | +13.2% | 691,000 | -20.2% | 0.08% | +50.0% |
Q1 2022 | $8,027,820 | +1355.5% | 866,000 | +1434.0% | 0.05% | +1150.0% |
Q4 2021 | $551,546 | -58.6% | 56,453 | +44.0% | 0.00% | -60.0% |
Q3 2021 | $1,331,948 | -76.5% | 39,198 | -74.7% | 0.01% | -72.2% |
Q2 2021 | $5,669,351 | +19.6% | 154,858 | +46.5% | 0.04% | -14.3% |
Q1 2021 | $4,740,799 | +326.0% | 105,727 | +442.2% | 0.04% | +366.7% |
Q4 2020 | $1,112,865 | -16.7% | 19,500 | -25.1% | 0.01% | -40.0% |
Q3 2020 | $1,336,000 | -33.6% | 26,050 | -22.7% | 0.02% | -37.5% |
Q2 2020 | $2,012,000 | -20.3% | 33,704 | -45.0% | 0.02% | -14.3% |
Q1 2020 | $2,524,000 | -11.8% | 61,315 | +33.3% | 0.03% | +27.3% |
Q4 2019 | $2,863,000 | – | 46,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |